Leonid Breydo

Leonid Breydo

Auto-generated profile, based on publicly available information

Leonid Breydo

Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida 33612, United States

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2007 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
RKRakez Kayed
Rakez Kayed
EHELIZABETH HEAD
ELIZABETH HEAD
FSFloyd Sarsoza
Floyd Sarsoza
TSTommy Saing
Tommy Saing
CCCarl W Cotman
Carl W Cotman
CGCharles G Glabe
Charles G Glabe
Background: Amyloid-related degenerative diseases are associated with the accumulation of misfolded proteins as amyloid fibrils in tissue. In Alzheimer disease (AD), amyloid accumulates in several distinct types of insoluble plaque deposits, intracellular Aβ and as soluble oligomers and the relationships between these deposits and their pathological significance remains unclear. Conformation dependent antibodies have been reported that specifically recognize distinct assembly states of amyloids, including prefibrillar oligomers and fibrils. Results: We immunized rabbits with a morphologically homogeneous population of Aβ42 fibrils. The resulting immune serum (OC) specifically recognizes fibrils, but not random coil monomer or prefibrillar oligomers, indicating fibrils display a distinct conformation dependent epitope that is absent in prefibrillar oligomers. The fibril epitope is also displayed by fibrils of other types of amyloids, indicating that the epitope is a generic feature of the polypeptide backbone. The fibril specific antibody also recognizes 100,000 × G soluble fibrillar oligomers ranging in size from dimer to greater than 250 kDa on western blots. The fibrillar oligomers recognized by OC are immunologically distinct from prefibrillar oligomers recognized by A11, even though their sizes overlap broadly, indicating that size is not a reliable indicator of oligomer conformation. The immune response to prefibrillar oligomers and fibrils is not sequence specific and antisera of the same specificity are produced in response to immunization with islet amyloid polypeptide prefibrillar oligomer mimics and fibrils. The fibril specific antibodies stain all types of amyloid deposits in human AD brain. Diffuse amyloid deposits stain intensely with anti-fibril antibody although they are thioflavin S negative, suggesting that they are indeed fibrillar in conformation. OC also stains islet amyloid deposits in transgenic mouse models of type II diabetes, demonstrating its generic specificity for amyloid fibrils. Conclusion: Since the fibril specific antibodies are conformation dependent, sequence-independent, and recognize epitopes that are distinct from those present in prefibrillar oligomers, they may have broad utility for detecting and characterizing the accumulation of amyloid fibrils and fibrillar type oligomers in degenerative diseases.

1 February 2012 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
LBLeonid Breydo
Leonid Breydo
JWJessica W. Wu
Jessica W. Wu
VUVladimir N. Uversky
Vladimir N. Uversky

15 July 2009 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
ECEmilie Cerf
Emilie Cerf
RSRabia Sarroukh
Rabia Sarroukh
STShiori Tamamizu-Kato
Shiori Tamamizu-Kato
LBLeonid Breydo
Leonid Breydo
SDSylvie Derclaye
Sylvie Derclaye
VRVincent Raussens
Vincent Raussens
AD (Alzheimer's disease) is linked to Aβ (amyloid β-peptide) misfolding. Studies demonstrate that the level of soluble Aβ oligomeric forms correlates better with the progression of the disease than the level of fibrillar forms. Conformation-dependent antibodies have been developed to detect either Aβ oligomers or fibrils, suggesting that structural differences between these forms of Aβ exist. Using conditions which yield well-defined Aβ-(1–42) oligomers or fibrils, we studied the secondary structure of these species by ATR (attenuated total reflection)–FTIR (Fouriertransform infrared) spectroscopy. Whereas fibrillar Aβ was organized in a parallel β-sheet conformation, oligomeric Aβ displayed distinct spectral features, which were attributed to an antiparallel β-sheet structure. We also noted striking similarities between Aβ oligomers spectra and those of bacterial outer membrane porins. We discuss our results in terms of a possible organization of the antiparallel β-sheets in Aβ oligomers, which may be related to reported effects of these highly toxic species in the amyloid pathogenesis associated with AD.

3 September 2013 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
LBLaura Blair
Laura Blair
BNBryce A. Nordhues
Bryce A. Nordhues
SHShannon E. Hill
Shannon E. Hill
KSK. Matthew Scaglione
K. Matthew Scaglione
JOJohn C. O’leary
John C. O’leary
CDChad A. Dickey
Chad A. Dickey
Aggregation of tau protein in the brain is associated with a class of neurodegenerative diseases known as tauopathies. FK506 binding protein 51 kDa (FKBP51, encoded by FKBP5) forms a mature chaperone complex with Hsp90 that prevents tau degradation. In this study, we have shown that tau levels are reduced throughout the brains of Fkbp5–/– mice. Recombinant FKBP51 and Hsp90 synergized to block tau clearance through the proteasome, resulting in tau oligomerization. Overexpression of FKBP51 in a tau transgenic mouse model revealed that FKBP51 preserved the species of tau that have been linked to Alzheimer’s disease (AD) pathogenesis, blocked amyloid formation, and decreased tangle load in the brain. Alterations in tau turnover and aggregate structure corresponded with enhanced neurotoxicity in mice. In human brains, FKBP51 levels increased relative to age and AD, corresponding with demethylation of the regulatory regions in the FKBP5 gene. We also found that higher FKBP51 levels were associated with AD progression. Our data support a model in which age-associated increases in FKBP51 levels and its interaction with Hsp90 promote neurotoxic tau accumulation. Strategies aimed at attenuating FKBP51 levels or its interaction with Hsp90 have the potential to be therapeutically relevant for AD and other tauopathies.

14 January 2015 in Molecules
Verified
Journal Article
Open access
PDF file
Irina M. KuznetsovaIrina M. Kuznetsova
Irina M. Kuznetsova
BZBoris Y. Zaslavsky
Boris Y. Zaslavsky
LBLeonid Breydo
Leonid Breydo
KTKonstantin K. Turoverov
Konstantin K. Turoverov
Vladimir N. UverskyVladimir N. Uversky
Vladimir N. Uversky
Macromolecular crowding is known to affect protein folding, binding of small molecules, interaction with nucleic acids, enzymatic activity, protein-protein interactions, and protein aggregation. Although for a long time it was believed that the major mechanism of the action of crowded environments on structure, folding, thermodynamics, and function of a protein can be described in terms of the excluded volume effects, it is getting clear now that other factors originating from the presence of high concentrations of “inert” macromolecules in crowded solution should definitely be taken into account to draw a more complete picture of a protein in a crowded milieu. This review shows that in addition to the excluded volume effects important players of the crowded environments are viscosity, perturbed diffusion, direct physical interactions between the crowding agents and proteins, soft interactions, and, most importantly, the effects of crowders on solvent properties.

1 February 2005 in Journal of Molecular Biology
Verified
Journal Article
Closed access
OBOlga V. Bocharova
Olga V. Bocharova
LBLeonid Breydo
Leonid Breydo
APAlexander S. Parfenov
Alexander S. Parfenov
VSVadim V. Vladimirovich Salnikov
Vadim V. Vladimirovich Salnikov
IBIlia V. Baskakov
Ilia V. Baskakov